LB
30
-8
JPM
57
-5
BEN
33
-5
NSC
47
-3
PEP
47
3
DFS
56
-4
HSIC
45
8
BK
66
-3
GIS
26
-14
EXR
48
2
GOOGL
48
-5
MU
35
3
MDT
59
-3
HBI
50
-2
STZ
50
7
CCI
28
3
WBA
48
-2
IVZ
48
-4
EXPD
37
6
RCL
79
2
LB
30
-8
JPM
57
-5
BEN
33
-5
NSC
47
-3
PEP
47
3
DFS
56
-4
HSIC
45
8
BK
66
-3
GIS
26
-14
EXR
48
2
GOOGL
48
-5
MU
35
3
MDT
59
-3
HBI
50
-2
STZ
50
7
CCI
28
3
WBA
48
-2
IVZ
48
-4
EXPD
37
6
RCL
79
2
Financhill
Back

TG Therapeutics Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
52

TGTX
TG Therapeutics

Last Price:
24.49
Seasonality Move:
21.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

TG Therapeutics Price Quote

$24.49
+0.04 (+-8.96%)
(Updated: November 5, 2024 at 5:44 AM ET)

TG Therapeutics Key Stats

Buy
52
TG Therapeutics (TGTX) is a Buy
Day range:
$22.92 - $25.05
52-week range:
$9.81 - $26.99
Dividend yield:
0%
P/E ratio:
271.67
P/S ratio:
10.89
P/B ratio:
21.32%
Volume:
9.1M
Avg. volume:
2.7M
1-year change:
121.07%
Market cap:
$3.8B
Revenue:
$233.7M
EPS:
$0.6

How Much Does TG Therapeutics Make?

Is TG Therapeutics Growing As A Company?

  • What Is TG Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 3.57%
  • What Is TG Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

TG Therapeutics Stock Price Performance

  • Did TG Therapeutics Stock Go Up Last Month?
    TG Therapeutics share price went up by 9.99% last month
  • Did TGTX's Share Price Rise Over The Last Year?
    TGTX share price rose by 121.07% over the past 1 year

What Is TG Therapeutics 52-Week High & Low?

TG Therapeutics Price To Free Cash Flow

Is It Risky To Buy TG Therapeutics?

  • How Much Debt Does TG Therapeutics Have?
    Total long term debt quarterly is $102.5M
  • How Much Cash Does TG Therapeutics Have?
    Cash and short term investments quarterly total is $217.3M
  • What Is TG Therapeutics’s Book Value Per Share?
    Book value per share is 1.15

Is TG Therapeutics Cash Flow Positive?

  • What Is TGTX Cash Flow From Operations?
    Cash flow from operations (TTM) is $67.8M
  • What Is TG Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $565K
  • What Is TG Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$82.5M

TG Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TGTX return on invested capital is 39.74%
  • What Is TG Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 28.89%
  • What Is TGTX Return On Equity?
    ROE is a measure of profitability and is 68.02%

TG Therapeutics Earnings Date & Stock Price

TG Therapeutics Competitors

  • Who Are TG Therapeutics's Competitors?
    Below is a list of companies who compete with TG Therapeutics or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • AdaptHealth Corp (AHCO)
    • Inspire Medical Systems Inc (INSP)
    • Rhythm Pharmaceuticals Inc (RYTM)
    • Varex Imaging Corp (VREX)

TG Therapeutics Dividend Yield

TG Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -40.92%
Revenue: 357.05% 2.66%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 40.50
Upside from Last Price: 65.64%

Major Shareholders

  • How many TGTX shares are owned by institutional investors?
    169.3M TGTX shares are owned by institutional investors
  • How many TGTX shares are owned by insiders?
    22.1M TGTX shares are owned by insiders